Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis

Overview of attention for article published in Frontiers in oncology, October 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 35,380 followers.

RT @FrontOncology: #3: Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicente…

04 Mar 2022

Reply Repost Favourite

#3: Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis 👩‍⚕️ Anne Zaremba 👉 https://t.co/eYlBeeibqt @AdrianaHepner @ProfGLongMIA @amenzies9 @MattCarlino @BroeckelmannPJ #WomenI

11 Feb 2022

Reply Repost Favourite

Published today: a new study from our clinical research unit 337 addressing the rare but serious side effect of grade 4 neutropenia secondary to immune checkpoint inhibition: https://t.co/zGpjLM9nqD

22 Oct 2021

Reply Repost Favourite

RT @BroeckelmannPJ: Data on rare hematologic side effects of immune checkpoint inhibition is increasingly emerging and severe cytopenias oc…

22 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.